Form 8-K - Current report:
SEC Accession No. 0001641172-25-021007
Filing Date
2025-07-25
Accepted
2025-07-25 16:05:26
Documents
12
Period of Report
2025-07-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38614
  Complete submission text file 0001641172-25-021007.txt   204010

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sonn-20250723.xsd EX-101.SCH 3017
3 XBRL LABEL FILE sonn-20250723_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE sonn-20250723_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3740
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 251151705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)